Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de William E. Rhodes
Age : 66
Public asset : 48,000 USD
Linked companies : Omega Diagnostics Group PLC - GENinCode Plc - OpGen Inc
Summary 
Founder of BD Ventures LLC, William E. Rhodes is a businessperson who has been at the helm of 8 different companies and is Non-Executive Chairman of OpGen, Inc., Chairman-Supervisory Board of Curetis GmbH (a subsidiary of OpGen, Inc.), Chairman-Supervisory Board at CytoSMART Technologies BV and Non-Executive Chairman of GENinCode UK Ltd. William E. Rhodes is also on the board of Omega Diagnostics Group Plc (former Independent Non-Executive Chairman) and Paramit Corp. and Operating Partner at Linden Manager LLC.

In the past he was Chairman-Supervisory Board at Curetis NV, President for The William-James Co., Senior Vice President of Becton, Dickinson & Co. and President of BD Biosciences, Systems & Reagents, Inc. (a subsidiary of Becton, Dickinson & Co.), Principal at Pfizer Central Research and Vice President of Johnson & Johnson Innovation JJDC, Inc.

William E. Rhodes received an undergraduate degree from Cornell University and a graduate degree from Seton Hall University.


Current positions of William E. Rhodes 
NameTitle Since
Omega Diagnostics Group PLC
(Medical Equipment, Supplies & Distribution)
Non-Executive Director 2021
GENinCode Plc
(Medical Equipment, Supplies & Distribution)
Non-Executive Chairman 2021
OpGen Inc
(Biotechnology & Medical Research)
Non-Executive Chairman 2020
Curetis GmbH Chairman-Supervisory Board -
CytoSMART Technologies BV Chairman-Supervisory Board -
Paramit Corp. Director 2014
Linden Manager LLC Operating Partner -


Holdings of William E. Rhodes 
NameEquities%Valuation
OpGen, Inc. (OPGN)
(Biotechnology & Medical Research)
15,0000.039%48,000 USD


William E. Rhodes: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
William E. Rhodes : Connections